Can Proteomics Refine Lung Screening? - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Can Proteomics Refine Lung Screening?

Proteomic biomarkers improve short-term lung cancer risk assessment.

  • By

  • Kathryn Wighton

  • June 1, 2026

  • 5 min

Share

Original Source(s)

Can Proteomics Refine Lung Screening?

  • by Kathryn Wighton

  • June 1, 2026

Related Content

Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer

Surfactant protein D: prognostic insights and emerging therapeutic roles in cancer

Prognostic significance of extracapsular extension in patients with non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a retrospective cohort study